DCGI Grants Emergency Use Authorisation To Gennova's Omicron-Specific mRNA-Based Booster Vaccine
DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies
'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political Pressure
Govt Panel Recommends Emergency Use Authorisation For Single-Dose 'Sputnik Light' Covid Vaccine
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review Proposals
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On Children
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In Trials
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: Report
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: Report
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: Report
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 Patients
Patanjali's Coronil Sees Sharp Increase In Demand Even As Questions Persist Over Efficacy Of Kit To Cure Covid-19 Patients
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
Zydus Cadila Begins Advance Production Of Its COVID Vaccine Candidate; To Seek Emergency Use Approval In May Or June: Report
Zydus Cadila's 'Virafin' Gets Emergency Use Approval From DCGI For Treating Moderate Covid-19 Infections
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: Report
Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per Month
India To Produce 850 Million Doses Of Sputnik V Covid-19 Vaccine Annually: RDIF
Timeline Of Russian Sputnik V Covid-19 Vaccine, Approved For Emergency Use In India
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's Recommendation
Pune-Based Gennova Set To Begin Clinical Trials Of India's First mRNA Covid-19 Vaccine This Month
With Phase 3 Trials Almost Complete, Dr Reddy's Seeks DCGI Nod For Emergency Use Of Russian Sputnik V Covid Vaccine
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 Vaccine
Dr Reddy's Gets Indian Drug Regulator's Nod For Phase-3 Trials Of Russian Sputnik V Covid-19 Vaccine In India
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel Soon
